Sowers M, Eyre D, Hollis B W, Randolph J F, Shapiro B, Jannausch M L, Crutchfield M
Department of Epidemiology, University of Michigan, Ann Arbor 48109-2029, USA.
J Clin Endocrinol Metab. 1995 Jul;80(7):2210-6. doi: 10.1210/jcem.80.7.7608281.
We measured two bone-formation markers, osteocalcin and bone-specific alkaline phosphatase, and one bone-resorption marker, N-telopeptide, in a longitudinal study in order to describe levels of these markers in lactating and nonlactating women after parturition. This 18-month postpartum period included an initial 6 months in which a 5% short-term bone loss occurred at both spine and femoral neck among breast-feeding women. The second part of the 18-month period was characterized by bone recovery among women who had lost bone. These bone-change characteristics provided an opportunity to evaluate the performance of biochemical markers during both bone loss and recovery and to identify environmental exposures during lactation associated with bone turnover. The eligible population comprised 115 women whose bone-turnover markers were measured at 2 weeks (baseline) and at 2, 4, 6, 12, and 18 months after parturition. Participants reported reproductive characteristics, diet, physical activity, use of medications, and infant-feeding practices at each contact. Women were grouped according to lactation duration: 0-1 months, 2-5 months, and 6 months or more. Women who breast-fed for at least 6 months had significantly different levels of all three bone-turnover markers compared with the levels in bottle-feeding controls, which were indicative of substantially increased bone turnover. Factors that predicted the difference in biochemical markers from baseline to 6-month values by regression analysis were lactation of 2-6 months duration and lactation for 6 months or more. Dietary calcium intake, physical activity level, and body size did not explain the differences in the change from the baseline level to the 6-month level, a period of time that corresponded with bone loss in the lactating women. Factors that predicted the differences in bone-turnover markers between 6 and 18 months (the time of bone-mass recovery) were lactation status and number of months to resumption of menses. By the 18-month observation, there was no difference in the mean values for the measured bone-turnover markers among the three lactation groups. This suggests that menstrual activity, rather than diet or physical activity, is the primary factor in bone-mass recovery after the bone loss of lactation.
在一项纵向研究中,我们测量了两种骨形成标志物——骨钙素和骨特异性碱性磷酸酶,以及一种骨吸收标志物——N-端肽,以描述产后哺乳期和非哺乳期女性这些标志物的水平。这个为期18个月的产后阶段包括最初的6个月,在此期间,母乳喂养的女性脊柱和股骨颈均出现了5%的短期骨质流失。18个月阶段的第二部分特点是骨质流失的女性出现骨质恢复。这些骨质变化特征为评估生化标志物在骨质流失和恢复过程中的表现,以及确定哺乳期与骨转换相关的环境暴露提供了机会。符合条件的人群包括115名女性,她们在产后2周(基线)以及产后2、4、6、12和18个月测量了骨转换标志物。参与者在每次随访时报告生殖特征、饮食、身体活动、药物使用情况和婴儿喂养方式。女性根据哺乳时间分组:0 - 1个月、2 - 5个月和6个月及以上。与人工喂养对照组相比,母乳喂养至少6个月的女性所有三种骨转换标志物的水平有显著差异,这表明骨转换大幅增加。通过回归分析预测从基线到6个月时生化标志物差异的因素是2 - 6个月的哺乳期以及6个月及以上的哺乳期。膳食钙摄入量、身体活动水平和体型并不能解释从基线水平到6个月水平变化的差异,这一时期与哺乳期女性的骨质流失相对应。预测6至18个月(骨质恢复时间)骨转换标志物差异的因素是哺乳状态和月经恢复的月数。到18个月观察期时,三个哺乳组中测量的骨转换标志物的平均值没有差异。这表明月经活动而非饮食或身体活动是哺乳期骨质流失后骨质恢复的主要因素。